Literature DB >> 10868725

Functional deterioration in adults with cerebral palsy.

N Ando1, S Ueda.   

Abstract

OBJECTIVE: To examine the problem of functional deterioration of patients with cerebral palsy.
SUBJECTS: Adults with cerebral palsy who work at community workshops throughout Japan. SETTINGS: Interviews combined with physical examinations. In the first part of the study a survey was conducted, to which 686 patients responded. In the second part, physicians conducted physical examinations on 163 patients. In the third part, the patients who had been examined in the second part were studied.
RESULTS: Functional deterioration was noted in approximately 35% of adult patients with cerebral palsy; it was higher among those with involuntary movements of the head and neck and abnormal movement patterns during locomotion. Deterioration was also noted among those who reported an inadequate work environment, such as poor posture during work and unsuitability of the desk, chairs and tools. Deterioration over a five-year period was noted in 8 of 122 patients.
CONCLUSION: Although the factors intrinsic to cerebral palsy are often responsible for the functional deterioration, environmental factors are not to be taken lightly if functional deterioration is to be prevented.

Entities:  

Mesh:

Year:  2000        PMID: 10868725     DOI: 10.1191/026921500672826716

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  13 in total

1.  Progressive resistance exercise increases strength but does not improve objective measures of mobility in young people with cerebral palsy.

Authors:  Diane L Damiano
Journal:  J Physiother       Date:  2014-05-09       Impact factor: 7.000

Review 2.  Importance of hip problems in daily activities for cerebral palsy patients.

Authors:  Elke Viehweger
Journal:  J Child Orthop       Date:  2013-09-15       Impact factor: 1.548

Review 3.  Health-related physical fitness for children with cerebral palsy.

Authors:  Désirée B Maltais; Lesley Wiart; Eileen Fowler; Olaf Verschuren; Diane L Damiano
Journal:  J Child Neurol       Date:  2014-05-11       Impact factor: 1.987

4.  Symptom burden in individuals with cerebral palsy.

Authors:  Adam T Hirsh; Juan C Gallegos; Kevin J Gertz; Joyce M Engel; Mark P Jensen
Journal:  J Rehabil Res Dev       Date:  2010

5.  Report of a workshop on research gaps in the treatment of cerebral palsy.

Authors:  Codrin Lungu; Deborah Hirtz; Diane Damiano; Paul Gross; Jonathan W Mink
Journal:  Neurology       Date:  2016-08-24       Impact factor: 9.910

6.  Assisting Forearm Function in Children With Movement Disorders via A Soft Wearable Robot With Equilibrium-Point Control.

Authors:  Jonathan Realmuto; Terence D Sanger
Journal:  Front Robot AI       Date:  2022-06-15

Review 7.  Cerebral palsy and aging.

Authors:  Peterson Haak; Madeleine Lenski; Mary Jo Cooley Hidecker; Min Li; Nigel Paneth
Journal:  Dev Med Child Neurol       Date:  2009-10       Impact factor: 5.449

8.  Ageing with cerebral palsy; what are the health experiences of adults with cerebral palsy? A qualitative study.

Authors:  Suzie Mudge; Juliet Rosie; Susan Stott; Denise Taylor; Nada Signal; Kathryn McPherson
Journal:  BMJ Open       Date:  2016-10-13       Impact factor: 2.692

9.  Determinants of participation and quality of life of young adults with cerebral palsy: longitudinal approach and comparison with the general population - SPARCLE 3 study protocol.

Authors:  Catherine Arnaud; Carine Duffaut; Jérôme Fauconnier; Silke Schmidt; Kate Himmelmann; Marco Marcelli; Lindsay Pennington; Joaquim Alvarelhão; Chirine Cytera; Marion Rapp; Virginie Ehlinger; Ute Thyen
Journal:  BMC Neurol       Date:  2021-06-30       Impact factor: 2.474

Review 10.  Determinants of muscle preservation in individuals with cerebral palsy across the lifespan: a narrative review of the literature.

Authors:  Olaf Verschuren; Ana R P Smorenburg; Yvette Luiking; Kristie Bell; Lee Barber; Mark D Peterson
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-02-02       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.